The corporate venture arm of AbbVie, investing in novel, transformational therapeutics at discovery and preclinical stages.

Talis Capital invests with high conviction at Seed & Series A across Europe and US. They help founders who see the future differently, build it.

ID Ventures is an early-stage venture capital firm that invests in promising Michigan-based, high-tech startups. They provide capital and work with ecosystem partners to support companies in scaling their teams and securing follow-on funding. Their focus is on supporting Michigan's startup community and bolstering the state's economy.

Phoenix Venture Partners is a venture capital firm specializing in bringing transformative technologies to market. They focus on advanced materials and innovative processes across various industries, providing hands-on support to entrepreneurs.

JME Ventures is a seed-stage investor focusing on Spanish startups with great founders building world-class solutions. They invest between €100k and €3m and prioritize a fast, transparent process while empowering founders.

Slow Ventures is an early-stage focused Venture Capital firm based out of San Francisco, Boston, and New York. Since 2011 Slow has deployed $800M+ across consumer, fintech, SaaS, crypto, healthcare, and the creator economy.

Eniac Ventures is a seed-stage venture capital firm that partners with daring founders. They bring deep experience as founders and operators, focusing on helping companies achieve product-market fit and navigate the challenges of the startup journey. Their investment areas include AI, data/dev tooling, SaaS, and healthcare.

Martin Ventures is a healthcare-focused investment firm that builds strong companies and partners with leaders pioneering them. They focus on optimizing convenience, clinical outcomes, access, and cost for patients. The firm has funded 50+ companies, with 30+ active and 23 exits.

H/L Ventures is a company-building ecosystem that helps mission-driven founders build valuable companies. They combine daily active engagement with portfolio companies and a focus on growth, impact, and diversity. Their unique model aligns the interests of entrepreneurs, investors, and society for mutual success.

Sinovation Ventures is a leading Chinese technology venture capital firm founded in 2009 by Dr. Kai-Fu Lee. They manage around $3B AUM across ten USD and RMB funds, investing in over 400 portfolio companies across the technology spectrum in China. Their focus is on helping great entrepreneurs build world-class companies.

M Ventures is the corporate venture capital arm of Merck, investing in early-stage biotechnology and technology companies.

Entrée Capital is a venture capital firm managed by former serial founders, with over $1.25B in assets under management across multiple funds. They invest globally in early-stage companies, from pre-seed to Series C, focusing on building strong businesses with great teams.